Sign in
4

Changes in Ownership

Verrica Pharmaceuticals Inc. Filed Acc 0001209191-23-043297

President and CEO sold 50,677 shares at $4.83 ($244,770)

  • President and CEO acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

White Ted · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-21 Grant or award : show line 1 in the form +150,000 179,466 D
2023-07-24 Sale : show line 2 in the form −50,677 $4.83 $244,770 128,789 D
Open-market sales · 50,677 sh · avg $4.83 · $244,770
Loading xslF345X05/doc4.xml…